Senescence in premalignant tumours
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Oncogene-induced senescence is a cellular response that may be crucial for protection against cancer development, but its investigation has so far been restricted to cultured cells that have been manipulated to overexpress an oncogene. Here we analyse tumours initiated by an endogenous oncogene, ras, and show that senescent cells exist in premalignant tumours but not in malignant ones. Senescence is therefore a defining feature of premalignant tumours that could prove valuable in the diagnosis and prognosis of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lastly, in mice and humans, a senescence response to strong mitogenic signals, such as those delivered by certain oncogenes, prevents premalignant lesions from progressing to malignant cancers [ 16 – 19 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [16]
In the citing paper
“In addition to identifying known cell-cycle regulators, these studies identified DCR2 as a common marker of senescence (Collado et al., 2005), later shown to characterize other types of senescence.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Collado et al., 2005
In the citing paper
“OIS or senescence induced by loss of a tumor suppressor was verified in vivo in human and murine preneoplastic lesions (Collado et al., 2005; Gorgoulis and Halazonetis, 2010; Kuilman and Peeper, 2009) and primary or treated neoplasias (Haugstetter et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Collado et al., 2005
In the citing paper
“Studies in various mouse models, supported by correlative evidence from human- derived tissue samples, have underscored the tumour- suppressive role of OIS 81,120-123 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [122]
In the citing paper
“This type of oncogene-induced senescence (OIS) is frequently observed in premalignant and benign tumour tissues [37 -39] but not in advanced malignant tumours, where cancer cells have already bypassed senescence.”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [38]
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
Tuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00085-6 · Cited by 798
p19ARF links the tumour suppressor p53 to Ras
Palmero, I., Pantoja, C., & Serrano, M. (1998) · Nature · doi:10.1038/25870 · Cited by 615
Self-citationTumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M., Campuzano, V., & Barbacid, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00191-0 · Cited by 571
Self-citation
Cited by
Items 601–700 of 1,005
Boquoi, A., Arora, S., Chen, T., Litwin, S., Koh, J., & Enders, G. H. (2015) · Aging Cell · doi:10.1111/acel.12279 · Cited by 49
“Nonetheless, real-time reverse-transcription–PCR for senescence marker mRNAs Dec1 and DcR2 (Collado et al., 2005) following 1 week of Dox treatment showed no substantial induction (Table S1, Supporting information).”
BackgroundPawlikowski, J. S., Adams, P. D., & Nelson, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.109728 · Cited by 71
“Analyses of human and murine tissues have shown the presence of senescent cells in lung adenomas, pancreatic intraductal neoplasia (PanIN lesions), prostatic intraepithelial neoplasia (PIN lesions) and melanocytic naevi, all of which are premalignant neoplasms (Braig et al., 2005; Chen et al., 2005; Collado et al., 20…”
BackgroundInositol Polyphosphate Multikinase Is a Coactivator of P53-Mediated Transcription and Cell Death
Xu, R., Sen, N., Paul, B. D., Snowman, A. M., Rao, F., Vandiver, M. S., Xu, J., & Snyder, S. H. (2013) · Science Signaling · doi:10.1126/scisignal.2003405 · Cited by 52
Lin, S., Yang, J., Elkahloun, A. G., Bandyopadhyay, A., Wang, L., Cornell, J. E., Yeh, I.-T., Agyin, J., Tomlinson, G., & Sun, L.-Z. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-10-0849 · Cited by 49
Sample-level enrichment analysis unravels shared stress phenotypes among multiple cancer types
Gundem, G., & López-Bigas, N. (2012) · Genome Medicine · doi:10.1186/gm327 · Cited by 56
“Senescence is an important tumor suppressive barrier to the progression of cancer [37-41].”
BackgroundKomseli, E.-S., Pateras, I. S., Krejsgaard, T., Stawiski, K., Rizou, S. V., Polyzos, A., Roumelioti, F.-M., Chiourea, M., Mourkioti, I., Paparouna, E., et al. (2018) · BMC Genomics · doi:10.1186/s12864-017-4375-1 · Cited by 51
TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation
George, B., Kantarjian, H. M., Baran, N., Krocker, J. D., & Rios, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910782 · Cited by 61
“The effects of mutation are many including neutral effects if the variant lies within a non-regulatory region, an increase in proliferation capacity or negative selection against cells if contained within essential genes [42,43].”
BackgroundAcquisition of Oxidative DNA Damage during Senescence: The First Step toward Carcinogenesis?
MARTIEN, S., & ABBADIE, C. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1404.010 · Cited by 51
Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro
Prencipe, M., Fitzpatrick, P., Gorman, S., Mosetto, M., Klinger, R., Furlong, F. M., Harrison, M. J., O’Connor, D. P., Roninson, I. B., O’Sullivan, J. M., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605419 · Cited by 57
“Supporting this function, following oncogene activation, senescent cells can be found in pre-malignant lesions but not in malignant tumours (Collado et al, 2005), identifying an involvement of cellular senescence in preventing tumour progression.”
BackgroundSenescence: an antiviral defense that is tumor suppressive?
Reddel, R. R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp274 · Cited by 50
MicroRNAs, Long Non-Coding RNAs, and Circular RNAs in the Redox Control of Cell Senescence
Lettieri-Barbato, D., Aquilano, K., Punziano, C., Minopoli, G., & Faraonio, R. (2022) · Antioxidants · doi:10.3390/antiox11030480 · Cited by 51
Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer
Kallenbach, J., Roozbahani, G. A., Horestani, M. H., & Baniahmad, A. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00941-0 · Cited by 59
“Senescence provides a mechanism to inhibit cancer cell growth but might have beneficial or adverse effects in a tumor [22].”
BackgroundKrejčí, P. (2013) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2013.11.001 · Cited by 51
Oncogene-induced senescence: An essential role for Runx
Terry, A., Cameron, E., Neil, J., & Kilbey, A. (2008) · Cell Cycle · doi:10.4161/cc.6368 · Cited by 46
“The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.”
BackgroundGoh, J., & Ladiges, W. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2014.06.004 · Cited by 56
A Natural Androgen Receptor Antagonist Induces Cellular Senescence in Prostate Cancer Cells
Hessenkemper, W., Roediger, J., Bartsch, S., Houtsmuller, A. B., van Royen, M. E., Petersen, I., Grimm, M., & Baniahmad, A. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1170 · Cited by 54
WSB1 overcomes oncogene-induced senescence by targeting ATM for degradation
Kim, J. J., Lee, S. B., Yi, S. Y., Han, S.-A., Kim, S., Lee, J., Tong, S., Yin, P., Gao, B., Zhang, J., et al. (2016) · Cell Research · doi:10.1038/cr.2016.148 · Cited by 58
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer
Costa, T. D. F., Zhuang, T., Lorent, J., Turco, E., Olofsson, H., Masià-Balagué, M., Zhao, M., Rabieifar, P., Robertson, N., Kuiper, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11510-4 · Cited by 52
Cell senescence as both a dynamic and a static phenotype
Young, A. R. J., Narita, M., & Narita, M. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_1 · Cited by 50
The paradox of senescent-marker positive cancer cells: challenges and opportunities
O’Sullivan, E. A., Wallis, R., Mossa, F., & Bishop, C. L. (2024) · npj Aging · doi:10.1038/s41514-024-00168-y · Cited by 62
“Subsequently, a series of landmark studies demonstrated that OIS occurs in vivo, including in the hematopoietic compartment (T-cell) 5 , naevi 6 – 8 , pituitary gland 9 , lung tissue 10,11 , prostate epithelium 12 – 14 and kidneys 15 .”
BackgroundPituitary senescence: The evolving role of Pttg
Chesnokova, V., & Melmed, S. K. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.012 · Cited by 53
“Thus, in addition to cell death programmes such as apoptosis and autophagia, senescence is increasingly recognized as a potent barrier for the development of true malignancies (Collado et al., 2005, Braig et al., 2005, Michaloglou et al., 2005).”
BackgroundMelanomagenesis: Overcoming the barrier of melanocyte senescence
Ha, L., Merlino, G., & Sviderskaya, E. V. (2008) · Cell Cycle · doi:10.4161/cc.7.13.6230 · Cited by 47
miR-125b induces cellular senescence in malignant melanoma
Nyholm, A. M., Lerche, C. M., Manfé, V., Biskup, E., Johansen, P., Morling, N., Thomsen, B. M., Glud, M., & Gniadecki, R. (2014) · BMC Dermatology · doi:10.1186/1471-5945-14-8 · Cited by 53
“Increased SA-beta-gal staining is seen in a variety of pre-malignant conditions, such as lung adenomas, congenital naevi, benign prostatic hyperplasia and premalignant prostatic intraepithelial neoplasia supporting the role of OIS in early control of malignancy [3,5,8,9].”
InfluentialMadsen, S. D., Russell, K. C., Tucker, H. A., Glowacki, J., Bunnell, B. A., & O’Connor, K. C. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0649-4 · Cited by 50
“A link of CD264 to senescence was first reported for oncogene-induced senescence; CD264 was upregulated in senescent premalignant tumors induced by ras but was downregulated in the ras-induced tumors that had escaped senescence and became malignant [23].”
InfluentialZheng, H., Seit-Nebi, A., Han, X., Aslanian, A., Tat, J., Liao, R., Yates, J. R., & Sun, P. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.04.013 · Cited by 48
“Recent studies have demonstrated that oncogene-induced senescence occurs in vivo and provides a bona fide barrier to tumorigenesis (Braig et al., 2005; Chen et al., 2005; Collado et al., 2005; Michaloglou et al., 2005; Narita and Lowe, 2005; Sun et al., 2007).”
BackgroundJames, M. F., Lelke, J. M., MacCollin, M., Plotkin, S. R., Stemmer-Rachamimov, A. O., Ramesh, V., & Gusella, J. F. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.09.002 · Cited by 57
“In other tumor types, recent studies have demonstrated the existence of senescent cells in premalignant, early stage tumors, but not in malignant forms (Chen et al. 2005; Collado et al. 2005).”
BackgroundLineage-Specific Restraint of Pituitary Gonadotroph Cell Adenoma Growth
Chesnokova, V., Zonis, S., Zhou, C., Ben-Shlomo, A., Wawrowsky, K., Toledano, Y., Tong, Y., Kovács, K., Scheithauer, B. W., & Melmed, S. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017924 · Cited by 50
“As cellular senescence appears to be bypassed in advanced malignancies [8,9,10], this antiproliferative mechanism may represent an initial impediment against oncogenic development [11].”
BackgroundJailbreak: Oncogene-induced senescence and its evasion
MDuff, F. K. E., & Turner, S. D. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.07.004 · Cited by 56
Drosos, Y., Escobar, D., Chiang, M.-Y., Roys, K., Valentine, V. A., Valentine, M. B., Rehg, J. E., Sahai, V., Begley, L., Ye, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11661-8 · Cited by 54
Muñoz-Galván, S., Lucena-Cacace, A., Pérez, M., Otero-Albiol, D., Gómez-Cambronero, J., & Carnero, A. (2018) · Oncogene · doi:10.1038/s41388-018-0527-2 · Cited by 52
Qiu, H., Jin, B., Wang, Z., Xu, B., Zheng, Q., Zhang, L., Zhu, L.-Y., Shi, S., Yuan, J.-B., Lin, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14614-4 · Cited by 51
Hernando, B., Dietzen, M., Parra, G., Gil‐Barrachina, M., Pitarch, G., Mahiques, L., Valcuende, F., McGranahan, N., & Martínez‐Cadenas, C. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.11.023 · Cited by 50
“Several reports from animal models support the idea that cell senescence may occur in tissues after acquiring a mitogenic mutation, preve nting carcinogenesis at an initial step [30, 31].”
BackgroundCancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing
Mongiardi, M. P., Pellegrini, M., Pallini, R., Levi, A., & Falchetti, M. L. (2021) · Cancers · doi:10.3390/cancers13030484 · Cited by 53
Qu, K., Lin, T., Wang, Z., Liu, S., Chang, H., Xu, X., Meng, F., Zhou, L., Wei, J., Tai, M., et al. (2014) · Frontiers of Medicine · doi:10.1007/s11684-014-0327-1 · Cited by 50
“Clinical and preclinical studies have indicated that many anti-tumor manipulations, including chemotherapeutic drugs and radiation, can induce tumor senescence [13,14].”
BackgroundAntitumor mechanisms when pRb and p53 are genetically inactivated
Zhu, L., Lu, Z., & Zhao, H.-T. (2014) · Oncogene · doi:10.1038/onc.2014.399 · Cited by 65
“Endogenous expression of a different KRAS mutant, KRASG12V, also did not induce Arf-p53 in MEF (22), but induced senescent lesions in the lung and pancreas (23).”
BackgroundMiyasaka, Y., Nagai, E., Yamaguchi, H., Fujii, K., Inoue, T., Ohuchida, K., Yamada, T., Mizumoto, K., Tanaka, M., & Tsuneyoshi, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0032 · Cited by 51
Axanova, L. S., Chen, Y. Q., McCoy, T. P., Sui, G., & Cramer, S. D. (2010) · The Prostate · doi:10.1002/pros.21201 · Cited by 54
“It was shown that human benign tumors contain senescent cells and that these cells disappear in their malignant counterparts [48,49].”
BackgroundKim, Y. H., Choi, Y. W., Han, J. H., Lee, J., Soh, E. Y., Park, S. H., Kim, J., & Park, T. J. (2014) · Neoplasia · doi:10.1016/j.neo.2014.10.005 · Cited by 52
“Senescence has been found in the pre-malignant stage of tumor but not in malignant tumor [15,33,34].”
BackgroundLópez-Vicente, L., Armengol, G., Pons, B., Coch, L., Argelaguet, E., LLeonart, M. E., Hernández‐Losa, J., de Torres, I. M., & y Cajal, S. R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3159 · Cited by 56
“been suggested that premalignant neoplastic lesions are rich in senescent tumor cells, restricting the growth of these lesions, whereas in most malignant tumors the majority of cells are proliferating (24, 25).”
BackgroundCaveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence
Volonté, D., Vyas, A. R., Chen, C., Đačić, S., Stabile, L. P., Kurland, B. F., Abberbock, S. R., Burns, T. F., Herman, J. G., Di, Y. P., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.815902 · Cited by 49
“(18) have found that senescence is restricted to premalignant lesions of the lung and is absent in malignant cancers in a mouse model of lung cancer expressing K-Ras.”
BackgroundAutoimmunity checkpoints as therapeutic targets in B cell malignancies
Müschen, M. (2018) · Nature reviews. Cancer · doi:10.1038/nrc.2017.111 · Cited by 51
Choi, S.-Y., Bin, B.-H., Kim, W., Lee, E., Lee, T. R., & Cho, E. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.02.016 · Cited by 55
Nagesh, P. K. B., Chowdhury, P., Hatami, E., Kumari, S., Kashyap, V. K., Tripathi, M. K., Wagh, S., Meibohm, B., Chauhan, S. C., Jaggi, M., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b14738 · Cited by 48
Yachida, N., Yoshihara, K., Yamaguchi, M., Suda, K., Tamura, R., & Enomoto, T. (2021) · Cancers · doi:10.3390/cancers13061439 · Cited by 50
“In a mouse model harboring a conditional oncogenic KRAS G12V allele, multiple lung adenomas and a few lung carcinomas developed [79].”
Backgroundp53 dependent cell‐cycle arrest triggered by chemotherapy in xenografted breast tumors
Varna, M., Lehmann‐Che, J., Turpin, E., Marangoni, E., Bouchtaoui, M. E., Jeanne, M., Grigoriu, C., Ratajczak, P., Lebœuf, C., Plassa, L., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.24049 · Cited by 49
Moh, M. C., Zhang, T., Lee, L. H., & Shen, S. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn226 · Cited by 50
Zhu, B., Ferry, C. H., Markell, L. K., Blazanin, N., Glick, A. B., Gonzalez, F. J., & Peters, J. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.551069 · Cited by 47
“DcR2 is a senescence marker highly expressed in senescent skin papillomas but not in normal skin (30).”
BackgroundMethodTourlakis, M. E., Zhang, S., Ball, H. L., Gandhi, R., Liu, H., Zhong, J., Yuan, J. S., Guidos, C. J., Durie, P. R., & Rommens, J. M. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1005288 · Cited by 47
“Senescence is considered a hallmark of premalignant tumours [85].”
BackgroundBhatia, B., Multani, A. S., Patrawala, L., Chen, X., Calhoun‐Davis, T., Zhou, J., Schroeder, L., Schneider‐Broussard, R., Shen, J., Pathak, S., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23222 · Cited by 47
Evidence of oncogene-induced senescence in thyroid carcinogenesis
Vizioli, M. G., Possik, P. A., Tarantino, E., Meissl, K., Borrello, M. G., Miranda, C., Anania, M. C., Pagliardini, S., Seregni, E., Pierotti, M. A., et al. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0240 · Cited by 47
Crosstalk between gut microbiota and cellular senescence: a vicious cycle leading to aging gut
Kawamoto, S., & Hara, E. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.12.004 · Cited by 49
Growth arrest signaling of the Raf/MEK/ERK pathway in cancer
Park, J. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1299-x · Cited by 51
Pungsrinont, T., Sutter, M. F., Ertingshausen, M. C. C. M., Lakshmana, G., Kokal, M., Khan, A. S., & Baniahmad, A. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00422-2 · Cited by 47
Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma
Feng, W., Xiao, J., Zhang, Z., Rosen, D. G., Brown, R. E., Liu, J., & Duan, X. (2007) · Modern Pathology · doi:10.1038/modpathol.3800927 · Cited by 54
“Senescence is a form of growth-arrested state described first in cultured fibroblasts where metabolically active cells undergo stable cell cycle arrest at the G1 phase”
Escape from oncogene-induced senescence is controlled by POU2F2 and memorized by chromatin scars
Martínez‐Zamudio, R. I., Stefa, A., de Freitas, J. A. N. L. F., Vasilopoulos, T., Simpson, M., Doré, G. R. G., Roux, P., Galan, M. A., Chokshi, R. J., Bischof, O., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100293 · Cited by 52
Chemical Strategies for the Detection and Elimination of Senescent Cells
García-Fleitas, J., García‐Fernández, A., Martí‐Centelles, V., Sancenón, F., Bernardos, A., & Martínez‐Máñez, R. (2024) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00794 · Cited by 49
Downregulation of lamin A by tumor suppressor AIMP3/p18 leads to a progeroid phenotype in mice
Oh, Y. S., Kim, D. G., Kim, G., Choi, E., Kennedy, B. K., Suh, Y., Park, B. J., & Kim, S. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00614.x · Cited by 45
“Cellular senescence serves as a major mechanism of tumor suppression (Collado et al., 2005, 2007).”
BackgroundHER2 Silences Tumor Suppression in Breast Cancer Cells by Switching Expression of C/EBPβ Isoforms
Estape, A. A., Tarragona, M., Morales, M. L. G., Guiu, M., Nadal, C., Massagué, J., & Gomis, R. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0869 · Cited by 52
“In certain types of cancer, tumor cells fail to trigger OIS owing to the loss of p16INK4a or p15INK4b, or the absence of Rb:E2F complexes (14, 15).”
BackgroundExtracellular acidosis triggers a senescence‐like phenotype in human melanoma cells
Böhme, I., & Bosserhoff, A. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12811 · Cited by 61
“Melanoma studies indicated that senescence might be a key feature of tumor pro‐ gression and tumor cells may arise from senescent tissue (Braig et al., 2005; Collado et al., 2005; Michaloglou et al., 2005).”
BackgroundMammalian cells acquire epigenetic hallmarks of human cancer during immortalization
Tommasi, S., Zheng, A., Weninger, A., Bates, S. E., Li, X. A., Wu, X., Hollstein, M., & Besaratinia, A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1051 · Cited by 45
“This suggests a role for senescent cells in the initiation and progression of tumorigenesis (2,5,6).”
BackgroundCLCA2 as a p53-Inducible Senescence Mediator
Tanikawa, C., Nakagawa, H., Furukawa, Y., Nakamura, Y., & Matsuda, K. (2012) · Neoplasia · doi:10.1593/neo.111700 · Cited by 48
“Because cellular senescence was observed in precancerous tissues [27,28], senescence is likely to function as a barrier for malignant transformation in the carcinogenesis process [29].”
BackgroundChallenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis
Qiu, W., & Su, G. H. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9408-2 · Cited by 50
Cellular Senescence as a Target in Cancer Control
Vergel, M., Marin, J. J., Estevez, P., & Carnero, A. (2011) · Journal of Aging Research · doi:10.4061/2011/725365 · Cited by 44
“Collado and coworkers [84] identified senescent cells in vivo after generating new”
BackgroundYao, B., Huang, S., Gao, D., Xie, J., Liu, N., & Fu, X. (2015) · International Wound Journal · doi:10.1111/iwj.12491 · Cited by 50
“Recently, more senescence markers were identified: p16 INK4A, DEC1, p15 INK4B and DCR2 (31) as well as cytological markers: senescence-associated heterochromatin foci (SAHFs) and senescence-associated DNA damage foci (SDFs) (32,33).”
BackgroundEffect of Cellular Senescence on the Growth of HER2-Positive Breast Cancers
Zacarias-Fluck, M. F., Morancho, B., Vicario, R., Luque Garcia, A., Escorihuela, M., Villanueva, J., Rubio, I. T., & Arribas, J. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv020 · Cited by 45
Harper, E. I., Sheedy, E. F., & Stack, M. S. (2018) · Cancers · doi:10.3390/cancers10070230 · Cited by 48
Mechanisms of Hydroxyurea‐Induced Cellular Senescence: An Oxidative Stress Connection?
Kapor, S., Čokić, V. P., & Santibanez, J. F. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7753857 · Cited by 54
pRb, a local chromatin organizer with global possibilities
Longworth, M. S., & Dyson, N. J. (2009) · Chromosoma · doi:10.1007/s00412-009-0238-0 · Cited by 54
“Senescence is a physiological process that is characterized by the cessation of cell proliferation, an irreversible cellcycle arrest, and the increased expression of specific markers such as β-galactosidase (Dimri et al. 1995; Narita et al. 2003; Collado et al. 2005).”
Large cell change of hepatocytes in chronic viral hepatitis represents a senescent-related lesion
Ikeda, H., Sasaki, M., Sato, Y., Harada, K., Zen, Y., Mitsui, T., & Nakanuma, Y. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.06.009 · Cited by 44
“Senescence in tumorigenesis is regarded as a defensive mechanism and evasion of senescence is thought to lead to malignancy [9,30].”
BackgroundDefining precancer: a grand challenge for the cancer community
Faupel‐Badger, J. M., Kohaar, I., Bahl, M., Chan, A. T., Campbell, J. D., Ding, L., Marzo, A. M. D., Maitra, A., Merrick, D. T., Hawk, E. T., et al. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00744-0 · Cited by 46
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
Xue, L., Nolla, H., Suzuki, A., Mak, T. W., & Winoto, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712059105 · Cited by 44
Kuo, M.-L., Sy, A. J., Xue, L., Chi, M., -C. Lee, M. T., Yen, T., Chiang, M.-I., Chang, L., Chu, P., & Yen, Y. (2012) · Scientific Reports · doi:10.1038/srep00822 · Cited by 43
Mariani, M. M., Maccoux, L. J., Matthäus, C., Diem, M., Hengstler, J. G., & Deckert, V. (2010) · Analytical Chemistry · doi:10.1021/ac1006987 · Cited by 51
Deregulated transcription factors in the emerging cancer hallmarks
Hasan, A., Khan, N. A., Shahab Uddin, M. S., Khan, A. Q., & Steinhoff, M. S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.001 · Cited by 48
Lowe, R., Overhoff, M. G., Ramagopalan, S. V., Garbe, J. C., Koh, J., Stampfer, M. R., Beach, D., Rakyan, V. K., & Bishop, C. L. (2015) · Genome biology · doi:10.1186/s13059-015-0748-4 · Cited by 50
“High levels of p16 expression, and thus possibly senescent cells, have been widely reported in such non-tumour cells [20, 21].”
BackgroundSelf-citationRole of 2-5A-dependent RNase-L in senescence and longevity
Andersen, J. B., Li, X. L., Judge, C. S., Zhou, A., Jha, B. K., Shelby, S., Zhou, L., Silverman, R. H., & Hassel, B. A. (2006) · Oncogene · doi:10.1038/sj.onc.1210111 · Cited by 49
“However, distinct profiles of gene expression are associated with senescence induced by different stimuli, and in specific cell types (Shelton et al., 1999; Yoon et al., 2004; Collado et al., 2005; Hardy et al., 2005), pointing out the need to better define the molecular components of the senescence response in specif…”
InfluentialSingh, K., Pruski, M. A., Bland, R., Younes, M., Guha, S., Thosani, N. C., Maitra, A., Cash, B. D., McAllister, F. M., Logsdon, C. D., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00490-5 · Cited by 46
Profiling influences of senescent and aged fibroblasts on prostate carcinogenesis
Dean, J. P., & Nelson, P. S. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604087 · Cited by 42
A High-Throughput Method to Identify Novel Senescence-Inducing Compounds
Ewald, J. A., Peters, N., Desotelle, J. A., Hoffmann, F. M., & Jarrard, D. F. (2009) · SLAS Discovery · doi:10.1177/1087057109340314 · Cited by 42
García‐Carracedo, D., Cai, Y., Qiu, W., Saeki, K., Friedman, R. A., Lee, A. H., Li, Y., Goldberg, E. M., Στρατικόπουλος, Η., Parsons, R. E., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0549 · Cited by 58
“It is therefore inferred that premalignant tumors that have undergone p16 or p53 loss are able to overcome OIS and progress to malignancy (51).”
BackgroundEpigenetic Control of Hematopoietic Stem Cell Aging The Case of Ezh2
de Haan, G., & GERRITS, A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1392.008 · Cited by 46
Programmed cell senescence: role of IL-6 in the pituitary
Sapochnik, M., Fuertes, M., & ARZT, E. S. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0026 · Cited by 44
Aging tumour cells to cure cancer: “pro-senescence” therapy for cancer
Calcinotto, A., & Alimonti, A. (2017) · Swiss Medical Weekly · doi:10.57187/smw.2017.14367 · Cited by 46
Kim, Y. H., & Park, T. J. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.1.295 · Cited by 44
Caron, J. M., Bannon, M., Rosshirt, L., Luis, J., Monteagudo, L., Caron, J. M., & Sternstein, G. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011788 · Cited by 46
“Over the last decade or so, the concept of chemotherapy-induced senescence has generated increasing interest [24,26,27,28,29].”
BackgroundMirzakhani, K., Kallenbach, J., Rasa, S. M. M., Ribaudo, F., Ungelenk, M., Ehsani, M., Gong, W., Gaßler, N., Leeder, M., Grimm, M., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02060-5 · Cited by 46
Changes in the mammary gland during aging and its links with breast diseases
Lin, J., Ye, S., Hao, K., Lin, L., Wu, X., Guo, M., Jiao, B., Chen, C., & Zhao, L. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023073 · Cited by 45
Effects of senescence on the tumour microenvironment and response to therapy
Reynolds, L. E., Maallin, S., Haston, S., Martínez-Barberá, J. P., Hodivala‐Dilke, K., & Pedrosa, A. (2023) · FEBS Journal · doi:10.1111/febs.16984 · Cited by 45
“Although cellular senescence can have an onco-suppressive role [12,13], it can also have detrimental effects, contributing to tumour initiation, progression, resistance to therapy and metastatic dissemination [14].”
Laine, A., & Westermarck, J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1942 · Cited by 36
Zhu, B., Ferry, C. H., Blazanin, N., Bility, M. T., Khozoie, C., Kang, B.-H., Glick, A. B., Gonzalez, F. J., & Peters, J. M. (2014) · Oncogene · doi:10.1038/onc.2013.477 · Cited by 41
Pan, Y., Meng, M., Zheng, N., Cao, Z., Yang, P., Xi, X., & Zhou, Q. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.024 · Cited by 42
“Noticeably, prematurely-senescent leukemia and cancer cells may regain robust tumorigenic capability [15-19], acquire a senescence-associated secretary phenotype (SASP), and actively secrete”
BackgroundSoto, D. R., Barton, C., Munger, K., & McLaughlin-Drubin, M. E. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006661 · Cited by 39
“OIS is a major barrier to malignant progression, and additional genetic or epigenetic alterations are needed for progression to invasive cancer [37].”
BackgroundActivatable senoprobes and senolytics: Novel strategies to detect and target senescent cells
Morsli, S., Doherty, G. J., & Muñoz-Espín, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111618 · Cited by 42
p53 governs telomere regulation feedback too, via TRF2
Horikawa, I., Fujita, K., & Harris, C. C. (2011) · Aging · doi:10.18632/aging.100271 · Cited by 44
Pancreatic Cancer Development and Progression: Remodeling the Model
Real, F. X., Cibrián–Uhalte, E., & Martinelli, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.033 · Cited by 49
Muñoz-Lorente, M. A., Martínez, P., Tejera, Á., Whittemore, K., Moisés-Silva, A. C., Bosch, F., & Blasco, M. A. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007562 · Cited by 40
Funes, J. M., Henderson, S. R., Kaufman, R., Flanagan, J. M., Robson, M. P., Pedley, B. R., Moncada, S., & Boshoff, C. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-20 · Cited by 44
“Moreover, analysis of previous microarray studies where investigators have transformed cells in vitro [47,48] showed that oncogenic transformation leads to Nrf2 down-regulation in both mouse and human cells (Additional file 12: Figure S10).”
BackgroundInfluentialThe extent of liver injury determines hepatocyte fate toward senescence or cancer
Wang, C., Chen, W., Wu, Y., You, P., Zheng, S., Liu, C.-C., Xiang, D., Wang, M., Cai, Y., Zhao, Q., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0622-x · Cited by 41
Induction and transmission of oncogene-induced senescence
Rattanavirotkul, N., Kirschner, K., & Chandra, T. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03638-0 · Cited by 44
Xu, Q., Ma, P., Hu, C., Chen, L., Xue, L., Wang, Z., Liu, M., Zhu, H., Xu, N., & Lu, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041862 · Cited by 39
“Several studies have confirmed that senescence is the initial barrier in cancer development because senescent cells have been found in precancerous lesions and premalignant tumors [15,18,19,20,21].”
Background
Metadata
- Authors
- Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., Beach, D., & Serrano, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Imperial College London (GB)
- Consejo Superior de Investigaciones Científicas (ES)
- Universidad Complutense de Madrid (ES)
- Corresponding author
- Serrano, Manuel
- ORCID
- Venue
- Nature
- Published
- 2005-08-04
- Volume
- 436
- Issue
- 7051
- Pages
- 642-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2067117191
- Cited by
- 1,482
- References
- 7
- Citations by year
- 2026: 31 · 2025: 40 · 2024: 59 · 2023: 58 · 2022: 57 · 2021: 74 · 2020: 87 · 2019: 55 · 2018: 53 · 2017: 68 · 2016: 67 · 2015: 73 · 2014: 76 · 2013: 81 · 2012: 81
- FWCI
- 46.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, oncogene-induced senescence, oncogenic Ras, lymphoma, SUV39H1, histone methyltransferase, epigenetic regulation, melanoma, p53, PTEN mutation, prostate cancer, tumor suppression, cancer diagnosis and prognosis
- MeSH terms
- Adenocarcinoma, Alleles, Animals, beta-Galactosidase, Cell Transformation, Neoplastic, Disease Models, Animal, Heterochromatin, Lung Neoplasms, Mice, Transgenic, Precancerous Conditions, Genes, ras, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Cellular Senescence, Disease Progression, Cyclin-Dependent Kinase Inhibitor p16, Oligonucleotide Array Sequence Analysis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.